ACOG OKs cell free DNA prenatal testing for high-risk women

November 30, 2012
ACOG OKs cell free DNA prenatal testing for high-risk women
Cell free fetal DNA testing is an effective screening tool for fetal aneuploidy and should be offered to high-risk women, but should not form part of routine prenatal laboratory assessment, according to a Committee Opinion published in the December issue of Obstetrics & Gynecology.

(HealthDay)—Cell free fetal DNA testing is an effective screening tool for fetal aneuploidy and should be offered to high-risk women, but should not form part of routine prenatal laboratory assessment, according to a Committee Opinion published in the December issue of Obstetrics & Gynecology.

The American College of Obstetricians and Gynecologists' Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee reviewed emerging clinical and scientific data on the use of noninvasive prenatal testing using cell free fetal DNA from the plasma of pregnant women.

The authors recommend that cell free fetal should only be offered to patients at increased risk of aneuploidy. Testing can identify about 98 percent of Down syndrome cases with a less than 0.5 percent false-positive rate. Testing has not been sufficiently evaluated in low-risk women or those with multiple gestations and consequently should not be offered to these groups. Pretest counseling should be used to inform patients of their choices and should emphasize that a negative test does not ensure an unaffected pregnancy. Testing can only screen for common trisomies and does not provide other genetic information about the pregnancy. Patients with a positive result should be referred for genetic counseling and offered invasive testing to confirm the results.

"Although no prospective trials of this technology are available, cell free fetal DNA appears to be the most effective screening for aneuploidy in high-risk ," the authors write.

Explore further: Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

More information: Full Text

Related Stories

Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

February 11, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in ...

Tests that use DNA from mother's blood to determine sex of fetus often effective

August 9, 2011
As a noninvasive method of determining the sex of a fetus, tests using cell-free fetal DNA obtained from the mother's blood after 7 weeks gestation performed well, while urine-based tests appear to be unreliable, according ...

Noninvasive genetic test for Down syndrome and Edwards syndrome highly accurate

June 5, 2012
Current screening strategies for Down syndrome, caused by fetal trisomy 21 (T21), and Edwards syndrome, caused by fetal trisomy 18 (T18), have false positive rates of 2 to 3%, and false negative rates of 5% or higher. Positive ...

Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use

October 17, 2011
A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice. The test can be ...

Study finds massively parallel sequencing can detect fetal aneuploidies, including Down syndrome

February 10, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that massively parallel sequencing can ...

Recommended for you

Women exposed to smoke while in womb more likely to miscarry

July 13, 2017
Women exposed to cigarette smoke while in their mothers' wombs are more likely to experience miscarriage as adults, according to new research from the University of Aberdeen.

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Aspirin reduces risk of pre-eclampsia in pregnant women

June 28, 2017
Taking a low-dose aspirin before bed can reduce the risk of pre-eclampsia, which can cause premature birth and, in extreme cases, maternal and foetal death.

The biology of uterine fluid: How it informs the fetus of mom's world

June 22, 2017
A developing fetus bathes in a mixture of cellular secretions and proteins unique to its mother's uterus. Before fertilization, the pH of uterine fluid helps create a conducive environment for sperm migration, and afterward, ...

New clues in puzzle over pre-eclampsia and cholesterol regulation

June 21, 2017
Scientists studying a mystery link between the dangerous pregnancy complication pre-eclampsia and an increased risk of heart disease in later life for both mother and child have uncovered important new clues.

Are maternal hormones different when carrying a boy or a girl?

June 15, 2017
With advances in prenatal testing it's now possible to find out whether a pregnancy will result in a male or female baby as early as eight weeks' gestation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.